Skip to main content
SpringerLink
Log in

Fecal Calprotectin in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease

  • Correspondence
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Puolanne AM, Kolho KL, Alfthan H, Ristimaki A, Mustonen H, Farkkila M. Rapid fecal calprotectin test and symptom index in monitoring the disease activity in colonic inflammatory bowel disease. Dig Dis Sci. (Epub ahead of print). doi:10.1007/s10620-017-4770-0.

  2. Gecse KB, Brandse JF, van Wilpe, S et al. Impact of disease location on fecal calprotectin levels in Crohn’s disease. Scand J Gastroenterol. 2015;50:841–847.

    Article  CAS  PubMed  Google Scholar 

  3. Ferreiro-Iglesias R, Barreiro-de Acosta M, Otero Santiago M, et al. Fecal calprotectin as predictor of relapse in patients with inflammatory bowel disease under maintenance infliximab therapy. J Clin Gastroenterol. 2016;50:147–151.

    Article  CAS  PubMed  Google Scholar 

  4. Mooiweer E, Severs M, Schipper ME, et al. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission. J Crohns Colitis. 2015;9:50–55.

    Article  PubMed  Google Scholar 

  5. Gisbert JP, Bermejo F, Perez-Calle JL, et al. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis. 2009;15:1190–1198.

    Article  PubMed  Google Scholar 

  6. Walkiewicz D, Werlin SL, Fish D, Scanlon M, Hanaway P, Kugathasan S. Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:669–673.

    Article  PubMed  Google Scholar 

  7. Lasson A, Stotzer PO, Ohman L, Isaksson S, Sapnara M, Strid H. The intra-individual variability of faecal calprotectin: A prospective study in patients with active ulcerative colitis. J Crohns Colitis. 2014;9:26–32.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, First Affiliated Hospital, China Medical University, No. 92 of Beier Road, Heping District, Shenyang City, 110001, Liaoning Province, China

    Cong Dai, Min Jiang & Ming-jun Sun

Authors
  1. Cong Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Min Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ming-jun Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

CD, MJ, and M-JS wrote the paper. CD and M-JS had the original idea for the paper. All authors reviewed and approved the final draft of the paper.

Corresponding author

Correspondence to Cong Dai.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dai, C., Jiang, M. & Sun, Mj. Fecal Calprotectin in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease. Dig Dis Sci 62, 3625–3626 (2017). https://doi.org/10.1007/s10620-017-4799-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-017-4799-0

Search

Navigation